Skip Ribbon Commands
Skip to main content
Sign In
eLearning
Online eLearning Orderable eLearning

We offer a variety of eLearning courses that will sharpen your knowledge of therapeutic apheresis, cell therapy and blood bank technology. Our eLearning programs address key terminology, concepts and principles related to our products and your work.

We offer two types of eLearning programs:

Online

Access our library of eLearning courses for easy online streaming.

Orderable

Order our self-study courses to train on your computer without the need for internet access; we will ship the content to you.

Online eLearning

Terumo BCT offers interactive web-based courses designed to support our customers in their efforts to continually build their knowledge.

Many of our therapeutic apheresis eLearning courses are eligible for CE credits.

Spectra Optia® Apheresis System

Online Training

Peripheral Vascular Access for Apheresis
Vascular access choice can impact patient experience, convenience, safety and cost of care. This online training module offers foundational guidance and considerations for furthering peripheral vascular access.

eLearning Courses

You can access the courses below only when logged into TERUMOBCT.COM with your account. To create a Terumo BCT account, click here.

COBE® Spectra Apheresis System

CE-Credited

Earn continuing education (CE) contact hours at no cost for viewing our eSessions presentations.

To begin, select the course you would like to view from the list of offerings below.

  • Each session consists of multiple modules and is approximately 1 hour long
  • Before the presentation begins, you will be asked to complete a registration form with your name, email address, organization, mailing address and license number
  • After completing this section, you will be directed to the first module
  • You must watch the entire module to receive contact hours; at the end of the module, close the module window and complete the evaluation form
  • You will not be eligible to receive credit for a session until you have submitted the evaluation form
  • You may view the sessions as many times as you like, but contact hours will only be issued for one viewing
  • You will be sent a certificate of completion within 1 month of viewing the session

Terumo BCT is an approved provider by the California Board of Registered Nursing, provider number CEP15146.

BLOOD BANKING eSESSIONS

For our blood banking customers, we offer the following courses:

Collection Optimization on the COBE Spectra System

Collection Optimization on the COBE Spectra System

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS
Duration: 55 minutes
Continuing Education Contact Hours: 1.1

This session is made up of two parts: Operational Principles of LRS Turbo Platelet Collection and COBE Spectra System Collection Optimization. Operational Principles of LRS Turbo Platelet Collection covers separation and leukoreduction on the COBE Spectra system, the difference between inlet:AC ratio and AC infusion rate. The importance of accurate donor total blood volume, the effect of donor comfort, yield and concentration, and platelet product quality are also reviewed. The Collection Optimization session covers procedural elements, data entry, procedure results and fluid balance.

Learning Objectives

Following completion of this course, the participant will be able to:

  • Describe indications for cellular depletions
  • Describe procedural elements
  • Describe data entry and procedure results
  • Describe fluid balance

Click the links below to register and view the Collection Optimization on the COBE Spectra System eSession Series

THERAPEUTIC APHERESIS AND CELLULAR THERAPY eSESSIONS

For our therapeutic apheresis and cellular therapy customers, we offer the following courses for the COBE Spectra system:

Performing Therapeutic Plasma Exchange (TPE) Procedures

Performing Therapeutic Plasma Exchange (TPE) Procedures

THERAPEUTIC APHERESIS AND CELLULAR THERAPY
Duration: 74 minutes
Continuing Education Contact Hours: 1.48

This eSession course is a three-part series on therapeutic plasma exchange (TPE) procedures on the COBE Spectra system.

Part one, Overview of TPE, details rational behind TPE, the role of TPE in the treatment of autoimmune diseases and the procedural elements of TPE.

Part two, Operational Principles of TPE, covers the meaning of the values displayed on the end result screen, the percentage disease mediator removed by a 1.0 plasma volume exchange, the correlation between plasma volume exchanged, percentage of disease mediator removed and therapeutic effectiveness of a TPE procedure, the distribution of AC added to the extra corporeal circuit; where the AC is coming from and where it is going, the data entry parameter which has an effect on the RBC/plasma interface, and the factors that determine the fluid balance.

Part three, Troubleshooting TPE, covers actions that must be taken before the procedure can be continued after an alarm condition, reasons for the message "No RBCs detected" and which detector prompts that message, actions that should be taken when a patient has a citrate reaction, risks to the extracorporeal circuit when it is increasing the Inlet: AC ratio, potential causes of the "Plasma line contamination detected" alarm, and lab values that should be checked when performing a plasma exchange procedure with albumin replacement.

Learning Objectives

  • Define TPE
  • Describe the role of TPE in the treatment of autoimmune diseases
  • Explain the meaning of the values displayed on the end result screen
  • State the percentage disease mediator removed by a 1.0 plasma volume exchange
  • Explain the correlation between plasma volume exchanged, percentage of disease mediator removed and therapeutic effectiveness of a TPE procedure
  • Explain the distribution of AC added to the extra corporeal circuit; where the AC is coming from and where it is going
  • Identify the data entry parameter which has an effect on the RBC/plasma interface
  • List two factors that determine the fluid balance
  • State what has to occur before the procedure can be continued after an alarm condition on the COBE Spectra system
  • State one reason for the message "No RBCs detected" and which detector prompts that message
  • State the first action that should be taken on the COBE Spectra system when a patient has a citrate reaction
  • State what the most likely risk to the extracorporeal circuit is when increasing the inlet:AC ratio on the COBE Spectra system, list two potential causes of the "Plasma line contamination detected" alarm on the COBE Spectra system.
  • List two lab values that should be checked when performing a plasma exchange procedure with albumin replacement

Click the links below to register and view the Performing Therapeutic Plasma Exchange Procedures eSessions Series

Performing Mononuclear Cell (MNC) Collection Procedures

Performing MNC Procedures

THERAPEUTIC APHERESIS AND CELLULAR THERAPY
Duration: 40 minutes
Continuing Education Contact Hours: 1

This eSession course is a four-part series discussing mononuclear cell (MNC) collection procedures on the COBE Spectra system.

Part one, Overview of MNC, covers the factors that may influence blood cell development or hematopoiesis, the types and functions of cells that form the MNC layer, the indication for performing an MNC procedure, and the factors that affect collection efficiency.

Part two, Operational Principles, covers MNC single-stage channel separation, the function of QuickStart, steps to achieve and maintain interface stability, and the factors to consider when optimizing the procedure.

Part three, Troubleshooting MNC, covers actions to take when a patient or donor has a citrate reaction, the effects that increasing the inlet:AC ratio has on the extracorporeal circuit and on the collected product, the potential causes of interface instability, the potential causes of a low CD34+ cell yield.

Part four includes a presentation,Using the White Blood Cell Functionally Closed (FC) Tubing Set, on the COBE Spectra system. This presentation covers the features that make the WBC-FC set a functionally closed system, the situations that cause the set to no longer be functionally closed, how to add ACD-A to the product bag, how to obtain a sample using the sample bulb assembly, and the reasons why it is necessary to reduce the inlet flow during rinseback.

Learning Objectives

Following completion of this course, the participant will be able to:

  • Briefly describe what factors may influence blood cell development or hematopoiesis
  • Name the types and functions of cells that form the MNC layer
  • List two indications for performing an MNC procedure
  • Identify three factors affecting collection procedure efficiency
  • Describe the COBE Spectra system single-stage channel separation process
  • Explain the function of Quick Start
  • List the four steps required to achieve and maintain interface stability
  • Name three factors to consider when optimizing MNC procedures
  • State the first action to take when a patient or donor has a citrate reaction
  • Describe the effect that increasing the inlet:AC ratio has on the extracorporeal circuit and on the collected product
  • List two potential causes of interface instability
  • List two potential causes of a low CD34+ cell yield

Click the links below to register and view the Performing MNC Procedures eSessions Series

Performing COBE Spectra System AutoPBSC Procedures

Performing COBE Spectra System AutoPBSC Procedures

THERAPEUTIC APHERESIS AND CELLULAR THERAPY
Duration: 52 minutes
Continuing Education Contact Hours: 1

This eSession course is a three-part series discussing AutoPBSC collection procedures on the COBE Spectra system.

Part one, Operational Principles of the COBE Spectra System AutoPBSC Collection Procedure, covers the indications for performing a Spectra AutoPBSC procedure, the three phases of collections, the effects of entered data on the calculation of Harvest phase frequency, and the functions of the CCM during the Spectra AutoPBSC procedure.

Part two, Troubleshooting Spectra AutoPBSC, covers the three alarm conditions that place the system in Assisted mode, the actions to take in response to the alarm "CCM Calibration Failure," and the difference between a dark spillover and a light spillover.

Part three of this series is a presentation on the use of Blood Prime on the COBE Spectra system. This presentation covers when to consider performing a Blood Prime, how to perform a Blood Prime and considerations when performing an apheresis procedure using a Blood Prime.

Learning Objectives

Following completion of this course, the participant will be able to:

  • State the indications for performing a Spectra AutoPBSC procedure
  • Describe the three phases of collection
  • Describe how to use Assisted mode
  • Explain the effect of entered data on the calculation of Harvest phase frequency
  • List the three functions of the CCM during a Spectra AutoPBSC procedure
  • Name three factors to consider when optimizing procedures
  • List the three alarm conditions that place the operator in Assisted mode
  • Explain the action in response to the alarm “CCM Calibration Failure”
  • Describe two circumstances when Assisted mode may be indicated
  • State the difference between a dark spillover and a light spillover

Click the links below to register and view the Performing COBE Spectra System AutoPBSC Procedures eSessions Series

Performing Cellular Processing Procedures

Performing Cellular Processing Procedures

THERAPEUTIC APHERESIS AND CELLULAR THERAPY
Duration: 79 minutes
Continuing Education Contact Hours: 1.5

This course covers all processing procedures on the Elutra® Cell Separation System and the COBE® 2991 Cell Processor, and bone marrow processing procedures using the COBE Spectra system.

Part one, Cellular Elutriation using the Elutra System, provides an overview of elutriation, basic operational principles of the Elutra system, starting product conditions required to achieve a successful monocyte enrichment, data entry considerations, and helpful hints for Elutra system users.

Part two, COBE 2991 Cell Processor Overview, provides a brief description of the operational principles, validated applications and the use of the LED program board.

Part three, Bone Marrow Processing using the COBE Spectra system, details the factors that must be considered prior to starting bone marrow processing procedure, the default values and procedure parameters for bone marrow processing procedures, the minimum RBC volumes required to perform a bone marrow processing procedures, and the process for determining when to process more than the default inlet volume.

Learning Objectives

Following completion of this course, the participant will be able to:

  • Describe the two cell characteristics that make the separation of cell populations possible during elutriation
  • List three choices that must be made prior to loading the disposable tubing set
  • Identify three calculations the Elutra system makes using the starting cell product data
  • State two effects of inaccurate starting cell product data on an elutriation procedure
  • List the four starting cell product conditions required to achieve a monocyte collection with an average purity of 80% and an average recovery of 60% using the Elutra system
  • Name four actions to avoid when performing an elutriation procedure
  • List the three operations that constitute a wash cycle using the COBE 2991 Cell Processor
  • State the three LED program board modes using the COBE 2991 Cell Processor
  • Explain STOP SELECT and define CALL, R.C. and P.C. when using the COBE 2991 Cell Processor
  • Describe how to program a Hold at the start of the Agitate Wash-In operation of the COBE 2991 Cell Processor
  • State the purpose of bone marrow processing
  • Identify the disposable tubing sets required for bone marrow processing
  • List three factors that must be considered prior to starting a bone marrow processing procedure
  • Name the default values and procedure parameters for bone marrow processing procedures and identify one factor that determines them
  • State the minimum RBC volume required to perform a bone marrow processing procedure
  • Describe how to determine when to process more than the default inlet volume processed

Click the links below to register and view the Bone Marrow Processing using the COBE Spectra System eSessions Series

Using the White Blood Cell Functionally Closed Tubing Set on the COBE Spectra System

Using the White Blood Cell Functionally Closed Tubing set on the COBE Spectra System

THERAPEUTIC APHERESIS AND CELLULAR THERAPY

Learning Objectives

Following completion of this course, the participant will be able to:

  • List four features that make the WBC-FC set a functionally closed system
  • Identify three situations that cause the set to no longer be functionally closed
  • Describe how to add ACD-A to the product bag
  • Explain how to obtain a sample using the sample bulb assembly
  • State why it is necessary to reduce the inlet flow during Rinseback

Non-CE-Credited

BLOOD BANKING ESESSIONS

COBE Spectra System Collection Optimizations

COBE Spectra System Collection Optimizations

BLOOD BANK TECHNOLOGY

Learning Objectives

Following completion of this course, the participant will be able to:

  • Indications for cellular depletions
  • Procedural elements
  • Data entry, procedure results
  • Fluid balance

Operational Principles of LRS® Turbo Platelet Collection

Operational Principles of LRS® Turbo Platelet Collection

BLOOD BANK TECHNOLOGY

Learning Objectives

Following completion of this course, the participant will be able to:

  • Discuss the COBE Spectra system separation and leukoreduction process
  • State the difference between inlet:AC ratio and AC infusion rate using the COBE Spectra system
  • Describe the importance of accurate donor total blood volume (TBV) and the effect on donor comfort
  • Define and differentiate between yield and concentration
  • Discuss how the COBE Spectra system monitors and controls platelet product quality

THERAPEUTIC APHERESIS AND CELLULAR THERAPY eSESSIONS

Overview of Therapeutic Plasma Exchange (TPE)

Overview of Therapeutic Plasma Exchange (TPE)

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

During this course, the participant will learn the following:

  • Definition of TPE
  • Rationale for TPE
  • Role of TPE in the treatment of autoimmune diseases
  • Procedural elements

Operational Principles of TPE

Operational Principles of TPE

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Explain the meaning of the values displayed on the end result screen
  • State the percentage disease mediator removed by a 1.0 plasma volume exchange
  • Explain the correlation between plasma volume exchanged, percentage of disease mediator removed and therapeutic effectiveness of a TPE procedure
  • Explain the distribution of AC added to the extracorporeal circuit; where the AC is coming from and where it is going
  • Identify the data entry parameter which has an effect on the RBC/plasma interface
  • List two factors that determine the fluid balance

Troubleshooting TPE

Troubleshooting TPE

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • State what has to occur before the procedure can be continued after an alarm condition on the COBE Spectra system
  • State one reason for the message "No RBCs detected" and which detector prompts that message
  • State the first action that should be taken, on the COBE Spectra system, when a patient has a citrate reaction
  • State what the most likely risk to the extracorporeal circuit is when increasing the inlet:AC ratio on the COBE Spectra system, list two potential causes of the "Plasma line contamination detected" alarm on the COBE Spectra system
  • List two lab values that should be checked when performing a plasma exchange procedure with albumin replacement

Using the White Blood Cell Functionally Closed Tubing Set on the COBE Spectra System

Using the White Blood Cell Functionally Closed Tubing Set on the COBE Spectra System

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • List four features that make the WBC-FC set a functionally closed system
  • Identify three situations that cause the set to no longer be functionally closed
  • Describe how to add ACD-A to the product bag
  • Explain how to obtain a sample using the sample bulb assembly
  • State why it is necessary to reduce the inlet flow during Rinseback

Overview of Mononuclear Cell (MNC) Collection Procedures

Overview of Mononuclear Cell (MNC) Collection Procedures

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Briefly describe the factors that may influence blood cell development or hematopoiesis.
  • Name the types and functions of cells that form the MNC layer.
  • List two indications for performing an MNC procedure.
  • Identify three factors affecting collection procedure efficiency.

MNC Collection Operational Principles

MNC Collection Operational Principles

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Describe the COBE Spectra system single-stage channel separation process
  • Explain the function of Quick Start
  • List the four steps required to achieve and maintain interface stability
  • Name three factors to consider when optimizing MNC procedures

Troubleshooting MNC Collection Procedures

Troubleshooting MNC Collection Procedures

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • State the first action to take when a patient or donor has a citrate reaction
  • Describe the effect that increasing the inlet:AC ratio has on the extracorporeal circuit and on the collected product
  • List two potential causes of interface instability
  • List two potential causes of a low CD34+ cell yield

COBE Spectra System Operational Principles of AutoPBSC Collection Procedures (Part 1 of 2)

COBE Spectra System Operational Principles of AutoPBSC Collection Procedures (Part 1 of 2)

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • State the indications for performing an AutoPBSC procedure
  • Describe the three phases of collection
  • Describe how to use Assisted mode
  • Explain the effect of entered data on the calculation of Harvest phase frequency
  • List the three functions of the CCM during an AutoPBSC procedure
  • Name three factors to consider when optimizing procedures

COBE Spectra System Operational Principles of AutoPBSC Collection Procedures (Part 2 of 2)

COBE Spectra System Operational Principles of AutoPBSC Collection Procedures (Part 2 of 2)

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • List the three alarm conditions that place the operator in Assisted mode
  • Explain the action in response to the alarm "CCM Calibration Failure"
  • Describe two circumstances when Assisted mode may be indicated
  • State the difference between a dark spillover and a light spillover

Bone Marrow Processing (BMP) Using the COBE Spectra System

Bone Marrow Processing (BMP) Using the COBE Spectra System

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • State the purpose of bone marrow processing
  • Identify the disposable tubing sets required for bone marrow processing
  • List three factors that must be considered prior to starting a bone marrow processing procedure
  • Name the default values and run parameters for bone marrow processing procedures and identify one factor that determines them
  • State the minimum RBC volume required to perform a bone marrow processing procedure
  • Describe how to determine when to process more than the default inlet volume processed

COBE Spectra System White Blood Cell (WBC) Depletion

COBE Spectra System White Blood Cell (WBC) Depletion

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Name the indication and the goal of a WBC depletion procedure
  • Identify two reasons for choosing an MNC procedure over a PMN procedure
  • Explain why processing 2 x TBV is more effective than processing 1 x TBV
  • List two factors that need to be taken into consideration when choosing the correct collect flow rate
  • Explain how to calculate the fluid balance during a WBC depletion procedure and how to maintain isovolemia during the procedure
  • Identify three factors affecting procedure efficiency

COBE Spectra System Platelet Depletion Procedures

COBE Spectra System Platelet Depletion Procedures

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Identify the indications for a platelet depletion procedure
  • Discuss management of fluid balance during a platelet depletion using the COBE Spectra system
  • Discuss options for which tubing set and filler to use for a platelet depletion
  • List four changes that you must make when programming a platelet depletion on a COBE Spectra system with software version 6.1 or version 7.0
  • Demonstrate how to calculate the appropriate collect flow rate for a platelet depletion

Use of Blood Prime on the COBE Spectra System

Use of Blood Prime on the COBE Spectra System

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • State when a Blood Prime should be considered
  • List two advantages of using an undiluted unit for the Blood Prime
  • Identify one thing that contributes to the effects of Blood Prime on the patient's Hct

Red Blood Cell Exchange (RBCX) and Depletion Procedures

Red Blood Cell Exchange (RBCX) and Depletion Procedures

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Name two indications for RBCX procedures
  • List two procedure goals of RBCX procedures
  • Identify four procedure variables that would prevent the expected outcome of that procedure
Elutra® Cell Separation System

Overview of Cellular Elutriation Using the Elutra System

Overview of Cellular Elutriation Using the Elutra System

THERAPEUTIC APHERESIS AND CELL THERAPY SYSTEMS

Following completion of this course, the participant will be able to:

  • Describe the two cell characteristics that make the separation of cell populations possible during elutriation
  • List three choices that must be made prior to loading the disposable tubing set
  • Identify three calculations the Elutra system makes using the starting cell product data
  • State two effects of inaccurate starting cell product data on an elutriation procedure
  • List the four starting cell product conditions required to achieve a monocyte collection with an average purity of 80% and an average recovery of 60%
  • Name four actions to avoid when performing an elutriation procedure

Orderable eLearning

Our self-study training can run on your computer without internet access. Choose from these courses:
Trima Accel® Automated Blood Collection System
This training, delivered on a USB flash drive, provides the materials you need to teach a new operator how to run the Trima Accel system. The training provides detailed instructor guides and offers students the chance to learn about the system through video demonstrations, simulations and self-guided activities. The training modules correspond to the 11 chapters found in the Trima Accel system operator's manual, including an overview of the system, running a procedure, responding to system messages, and cleaning and configuring the system.
COBE® Spectra Apheresis System
Comparable to the first day of new operator training, this CD-ROM offers a collection of videos, interactive simulations and self-guided tests, providing basic knowledge of the COBE Spectra system. This training consists of eight modules that address a variety of topics, such as an overview of therapeutic apheresis, anticoagulation management and how to effectively perform procedures on the COBE Spectra system.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​